The TM region of the eye is exposed to a constant low level of oxidative insult. The ability of TM cells to counter oxidative damage is critical to their survival since H
2O
2 in the human aqueous humor (AH) may be as high as 25 μM.
12 H
2O
2 is believed to be constantly generated through a light-dependent reaction with iris melanin.
13,14 In the current study, previous H
2O
2 studies
10 were expanded upon using a longer exposure time (24 hours vs. 30 minutes) and lower concentrations of H
2O
2 (<4 mM vs. >20 mM) in order to mimic the chronic low-level oxidative stress that TM cells experience in vivo. The studies were performed in low-passage primary cultures of TM cells to eliminate the complication of analyzing data from TM cells with different metabolic capabilities, as is noted with older TM cultures.
15 Antioxidants were chosen to include both metabolic (intrinsic) agents as well as dietary agents. For the latter, coumaric acid was selected because of its ability to lessen UV damage in cornea, and resveratrol because of its anti-inflammatory effects in TM cells. For the former, ascorbate, urate, and GSH were chosen because these antioxidants had been detected in the AH.
For metabolic agents, biological molecules with intrinsic antioxidant or chemical-reducing abilities that had been detected in the AH of the eye were selected. The TM region of the eye contains high intracellular levels of rGSH,
16 a cofactor that supplies reducing equivalents to glutathione peroxidase (H
2O
2 neutralizing enzymes). Submillimolar levels of rGSH have been reported in the AH, and these are reduced in patients with pseudoexfoliation syndrome.
17 Ascorbate (vitamin C) is a mitochondrial enzyme substrate that can act as an antioxidant either indirectly by generating reducing equivalents (NADPH) via the citric acid cycle or directly through the action of ascorbate peroxidases. Ascorbate levels in the AH range between 0.86 and 1.3 mM.
14,18,19 Like ascorbate, urate is a powerful antioxidant and reducing agent detectable in the AH in a range between 0.15-0.21 mM.
18 However, urate (but not ascorbate) is higher in the AH of patients with poor trabeculectomy outcomes,
18 and serum hyperuricemia is noted in patients with POAG.
20 Ascorbate (1 mM) and urate (0.2 mM) were used at their AH concentrations, while rGSH (1 mM), because of the question of permeability, was used at a higher concentration (1 mM) than its AH concentration (∼0.15 mM).
For the selection of exogenous agents, antioxidant molecules were selected that had been shown to be beneficial to countering oxidative stress in ocular tissues. ρ-coumarate has been shown to lessen ultraviolet (UV) damage to the cornea when applied topically to rabbits.
21 Resveratrol, a phenolic compound from grapes, has been shown to reduce ROS and inhibit expression of inflammatory markers in TM cells exposed to H
2O
2.
11 Extensive dose-response curves were not performed for coumarate/resveratrol, but the concentrations used were verified to be nontoxic.
To determine the extent of H
2O
2 damage on TM cells, both the calcein uptake to assay plasma membrane integrity (
Table 3) and MTT (
Tables 1 and
2) to assay mitochondrial function were used. Care was taken to wash cells thoroughly between H
2O
2 exposure and subsequent assays. The results demonstrated rescue of H
2O
2-induced TM injury by resveratrol, ascorbate, and rGSH (in that rank order of effectiveness). All three compounds mitigated the H
2O
2-induced loss of mitochondrial activity as well as cell death. Ascorbate and resveratrol were also effective at reducing production of intracellular oxygen species, a metric for oxidative damage. The effectiveness of these compounds was greatest when administered during H
2O
2 challenge. However, pretreating cultured TM cells with these antioxidants also was effective at preventing subsequent H
2O
2-induced changes, which suggested that these compounds had a lasting metabolic or intracellular effect. The protective effect of rGSH resulted from three possible mechanisms. Either the organic ion transporting polypeptides (organic anion-transporting polypeptide [OATP]) or the multi-drug resistance-associated protein transporter have been hypothesized to import rGSH.
22 OATP subtypes are present in endothelial cells of the human TM and Schlemm canal where they transport prostaglandins from the AH.
23 Secondly, rGSH could act extracellularly either by directly neutralizing hydrogen H
2O
2 or by reducing disulfide bonds in transmembrane proteins that had been oxidized. Alternatively, rGSH could have reduced another metabolite present in the media (e.g., lactate to pyruvate) that could itself have been easily transported in the TM cells.
Further investigation of these compounds is needed to determine their long-term effectiveness at reducing H
2O
2 damage in TM cells and to better understand how these in vitro findings could translate to in vivo experiments. Possible studies would involve showing that application of antioxidants can help ameliorate disease progression in animal models of glaucoma and macular degeneration (and other eye diseases linked with oxidative stress). The use of antioxidants to treat eye diseases, as illustrated by ρ-coumarate's ability to lessen UV damage to the cornea when applied topically,
21 indicated a possible dosing mechanism that bypassed issues with absorption and bioavailability of oral dosing. Furthermore, coupling these agents with extended release vehicles for intraocular injection could result in a consistent antioxidant influence on local free radical formation leading to enhanced therapeutic outcomes.